Global Fabry Disease Therapeutic Market Size, Status and Forecast 2023-2027

Report ID: 1012373 | Published Date: Jan 2025 | No. of Page: 118 | Base Year: 2024 | Rating: 4.5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Fabry Disease Therapeutic Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Enzyme Replacement Therapy
        1.2.3 Alternative therapies
    1.3 Market by Application
        1.3.1 Global Fabry Disease Therapeutic Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Other
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Fabry Disease Therapeutic Market Perspective (2016-2027)
    2.2 Fabry Disease Therapeutic Growth Trends by Regions
        2.2.1 Fabry Disease Therapeutic Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Fabry Disease Therapeutic Historic Market Share by Regions (2016-2021)
        2.2.3 Fabry Disease Therapeutic Forecasted Market Size by Regions (2022-2027)
    2.3 Fabry Disease Therapeutic Industry Dynamic
        2.3.1 Fabry Disease Therapeutic Market Trends
        2.3.2 Fabry Disease Therapeutic Market Drivers
        2.3.3 Fabry Disease Therapeutic Market Challenges
        2.3.4 Fabry Disease Therapeutic Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Fabry Disease Therapeutic Players by Revenue
        3.1.1 Global Top Fabry Disease Therapeutic Players by Revenue (2016-2021)
        3.1.2 Global Fabry Disease Therapeutic Revenue Market Share by Players (2016-2021)
    3.2 Global Fabry Disease Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Fabry Disease Therapeutic Revenue
    3.4 Global Fabry Disease Therapeutic Market Concentration Ratio
        3.4.1 Global Fabry Disease Therapeutic Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Fabry Disease Therapeutic Revenue in 2020
    3.5 Fabry Disease Therapeutic Key Players Head office and Area Served
    3.6 Key Players Fabry Disease Therapeutic Product Solution and Service
    3.7 Date of Enter into Fabry Disease Therapeutic Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Fabry Disease Therapeutic Breakdown Data by Type
    4.1 Global Fabry Disease Therapeutic Historic Market Size by Type (2016-2021)
    4.2 Global Fabry Disease Therapeutic Forecasted Market Size by Type (2022-2027)

5 Fabry Disease Therapeutic Breakdown Data by Application
    5.1 Global Fabry Disease Therapeutic Historic Market Size by Application (2016-2021)
    5.2 Global Fabry Disease Therapeutic Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Fabry Disease Therapeutic Market Size (2016-2027)
    6.2 North America Fabry Disease Therapeutic Market Size by Type
        6.2.1 North America Fabry Disease Therapeutic Market Size by Type (2016-2021)
        6.2.2 North America Fabry Disease Therapeutic Market Size by Type (2022-2027)
        6.2.3 North America Fabry Disease Therapeutic Market Size by Type (2016-2027)
    6.3 North America Fabry Disease Therapeutic Market Size by Application
        6.3.1 North America Fabry Disease Therapeutic Market Size by Application (2016-2021)
        6.3.2 North America Fabry Disease Therapeutic Market Size by Application (2022-2027)
        6.3.3 North America Fabry Disease Therapeutic Market Size by Application (2016-2027)
    6.4 North America Fabry Disease Therapeutic Market Size by Country
        6.4.1 North America Fabry Disease Therapeutic Market Size by Country (2016-2021)
        6.4.2 North America Fabry Disease Therapeutic Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Fabry Disease Therapeutic Market Size (2016-2027)
    7.2 Europe Fabry Disease Therapeutic Market Size by Type
        7.2.1 Europe Fabry Disease Therapeutic Market Size by Type (2016-2021)
        7.2.2 Europe Fabry Disease Therapeutic Market Size by Type (2022-2027)
        7.2.3 Europe Fabry Disease Therapeutic Market Size by Type (2016-2027)
    7.3 Europe Fabry Disease Therapeutic Market Size by Application
        7.3.1 Europe Fabry Disease Therapeutic Market Size by Application (2016-2021)
        7.3.2 Europe Fabry Disease Therapeutic Market Size by Application (2022-2027)
        7.3.3 Europe Fabry Disease Therapeutic Market Size by Application (2016-2027)
    7.4 Europe Fabry Disease Therapeutic Market Size by Country
        7.4.1 Europe Fabry Disease Therapeutic Market Size by Country (2016-2021)
        7.4.2 Europe Fabry Disease Therapeutic Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Fabry Disease Therapeutic Market Size (2016-2027)
    8.2 Asia-Pacific Fabry Disease Therapeutic Market Size by Type
        8.2.1 Asia-Pacific Fabry Disease Therapeutic Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Fabry Disease Therapeutic Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Fabry Disease Therapeutic Market Size by Type (2016-2027)
    8.3 Asia-Pacific Fabry Disease Therapeutic Market Size by Application
        8.3.1 Asia-Pacific Fabry Disease Therapeutic Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Fabry Disease Therapeutic Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Fabry Disease Therapeutic Market Size by Application (2016-2027)
    8.4 Asia-Pacific Fabry Disease Therapeutic Market Size by Region
        8.4.1 Asia-Pacific Fabry Disease Therapeutic Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Fabry Disease Therapeutic Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Fabry Disease Therapeutic Market Size (2016-2027)
    9.2 Latin America Fabry Disease Therapeutic Market Size by Type
        9.2.1 Latin America Fabry Disease Therapeutic Market Size by Type (2016-2021)
        9.2.2 Latin America Fabry Disease Therapeutic Market Size by Type (2022-2027)
        9.2.3 Latin America Fabry Disease Therapeutic Market Size by Type (2016-2027)
    9.3 Latin America Fabry Disease Therapeutic Market Size by Application
        9.3.1 Latin America Fabry Disease Therapeutic Market Size by Application (2016-2021)
        9.3.2 Latin America Fabry Disease Therapeutic Market Size by Application (2022-2027)
        9.3.3 Latin America Fabry Disease Therapeutic Market Size by Application (2016-2027)
    9.4 Latin America Fabry Disease Therapeutic Market Size by Country
        9.4.1 Latin America Fabry Disease Therapeutic Market Size by Country (2016-2021)
        9.4.2 Latin America Fabry Disease Therapeutic Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Fabry Disease Therapeutic Market Size (2016-2027)
    10.2 Middle East & Africa Fabry Disease Therapeutic Market Size by Type
        10.2.1 Middle East & Africa Fabry Disease Therapeutic Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Fabry Disease Therapeutic Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Fabry Disease Therapeutic Market Size by Type (2016-2027)
    10.3 Middle East & Africa Fabry Disease Therapeutic Market Size by Application
        10.3.1 Middle East & Africa Fabry Disease Therapeutic Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Fabry Disease Therapeutic Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Fabry Disease Therapeutic Market Size by Application (2016-2027)
    10.4 Middle East & Africa Fabry Disease Therapeutic Market Size by Country
        10.4.1 Middle East & Africa Fabry Disease Therapeutic Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Fabry Disease Therapeutic Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Amicus therapeutics
        11.1.1 Amicus therapeutics Company Details
        11.1.2 Amicus therapeutics Business Overview
        11.1.3 Amicus therapeutics Fabry Disease Therapeutic Introduction
        11.1.4 Amicus therapeutics Revenue in Fabry Disease Therapeutic Business (2016-2021)
        11.1.5 Amicus therapeutics Recent Development
    11.2 Takeda
        11.2.1 Takeda Company Details
        11.2.2 Takeda Business Overview
        11.2.3 Takeda Fabry Disease Therapeutic Introduction
        11.2.4 Takeda Revenue in Fabry Disease Therapeutic Business (2016-2021)
        11.2.5 Takeda Recent Development
    11.3 Genzyme-Sanofi
        11.3.1 Genzyme-Sanofi Company Details
        11.3.2 Genzyme-Sanofi Business Overview
        11.3.3 Genzyme-Sanofi Fabry Disease Therapeutic Introduction
        11.3.4 Genzyme-Sanofi Revenue in Fabry Disease Therapeutic Business (2016-2021)
        11.3.5 Genzyme-Sanofi Recent Development
    11.4 Protalix
        11.4.1 Protalix Company Details
        11.4.2 Protalix Business Overview
        11.4.3 Protalix Fabry Disease Therapeutic Introduction
        11.4.4 Protalix Revenue in Fabry Disease Therapeutic Business (2016-2021)
        11.4.5 Protalix Recent Development
    11.5 Sanofi-Aventis LLC
        11.5.1 Sanofi-Aventis LLC Company Details
        11.5.2 Sanofi-Aventis LLC Business Overview
        11.5.3 Sanofi-Aventis LLC Fabry Disease Therapeutic Introduction
        11.5.4 Sanofi-Aventis LLC Revenue in Fabry Disease Therapeutic Business (2016-2021)
        11.5.5 Sanofi-Aventis LLC Recent Development
    11.6 Novartis Pharmaceuticals
        11.6.1 Novartis Pharmaceuticals Company Details
        11.6.2 Novartis Pharmaceuticals Business Overview
        11.6.3 Novartis Pharmaceuticals Fabry Disease Therapeutic Introduction
        11.6.4 Novartis Pharmaceuticals Revenue in Fabry Disease Therapeutic Business (2016-2021)
        11.6.5 Novartis Pharmaceuticals Recent Development
    11.7 Pfizer
        11.7.1 Pfizer Company Details
        11.7.2 Pfizer Business Overview
        11.7.3 Pfizer Fabry Disease Therapeutic Introduction
        11.7.4 Pfizer Revenue in Fabry Disease Therapeutic Business (2016-2021)
        11.7.5 Pfizer Recent Development
    11.8 Bristol-Myers Squibb Company
        11.8.1 Bristol-Myers Squibb Company Company Details
        11.8.2 Bristol-Myers Squibb Company Business Overview
        11.8.3 Bristol-Myers Squibb Company Fabry Disease Therapeutic Introduction
        11.8.4 Bristol-Myers Squibb Company Revenue in Fabry Disease Therapeutic Business (2016-2021)
        11.8.5 Bristol-Myers Squibb Company Recent Development
    11.9 GlaxoSmithKline plc
        11.9.1 GlaxoSmithKline plc Company Details
        11.9.2 GlaxoSmithKline plc Business Overview
        11.9.3 GlaxoSmithKline plc Fabry Disease Therapeutic Introduction
        11.9.4 GlaxoSmithKline plc Revenue in Fabry Disease Therapeutic Business (2016-2021)
        11.9.5 GlaxoSmithKline plc Recent Development
    11.10 Amgen Inc.
        11.10.1 Amgen Inc. Company Details
        11.10.2 Amgen Inc. Business Overview
        11.10.3 Amgen Inc. Fabry Disease Therapeutic Introduction
        11.10.4 Amgen Inc. Revenue in Fabry Disease Therapeutic Business (2016-2021)
        11.10.5 Amgen Inc. Recent Development
    11.11 Teva pharmaceutical Industries Ltd.
        11.11.1 Teva pharmaceutical Industries Ltd. Company Details
        11.11.2 Teva pharmaceutical Industries Ltd. Business Overview
        11.11.3 Teva pharmaceutical Industries Ltd. Fabry Disease Therapeutic Introduction
        11.11.4 Teva pharmaceutical Industries Ltd. Revenue in Fabry Disease Therapeutic Business (2016-2021)
        11.11.5 Teva pharmaceutical Industries Ltd. Recent Development
    11.12 Merc & Co.
        11.12.1 Merc & Co. Company Details
        11.12.2 Merc & Co. Business Overview
        11.12.3 Merc & Co. Fabry Disease Therapeutic Introduction
        11.12.4 Merc & Co. Revenue in Fabry Disease Therapeutic Business (2016-2021)
        11.12.5 Merc & Co. Recent Development
    11.13 AbbVie Inc.
        11.13.1 AbbVie Inc. Company Details
        11.13.2 AbbVie Inc. Business Overview
        11.13.3 AbbVie Inc. Fabry Disease Therapeutic Introduction
        11.13.4 AbbVie Inc. Revenue in Fabry Disease Therapeutic Business (2016-2021)
        11.13.5 AbbVie Inc. Recent Development
    11.14 Takeda Pharmaceutical Co. Ltd.
        11.14.1 Takeda Pharmaceutical Co. Ltd. Company Details
        11.14.2 Takeda Pharmaceutical Co. Ltd. Business Overview
        11.14.3 Takeda Pharmaceutical Co. Ltd. Fabry Disease Therapeutic Introduction
        11.14.4 Takeda Pharmaceutical Co. Ltd. Revenue in Fabry Disease Therapeutic Business (2016-2021)
        11.14.5 Takeda Pharmaceutical Co. Ltd. Recent Development
    11.15 Green Cross Corp.
        11.15.1 Green Cross Corp. Company Details
        11.15.2 Green Cross Corp. Business Overview
        11.15.3 Green Cross Corp. Fabry Disease Therapeutic Introduction
        11.15.4 Green Cross Corp. Revenue in Fabry Disease Therapeutic Business (2016-2021)
        11.15.5 Green Cross Corp. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Fabry Disease Therapeutic Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Enzyme Replacement Therapy
    Table 3. Key Players of Alternative therapies
    Table 4. Global Fabry Disease Therapeutic Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 5. Global Fabry Disease Therapeutic Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Fabry Disease Therapeutic Market Size by Regions (2016-2021) & (US$ Million)
    Table 7. Global Fabry Disease Therapeutic Market Share by Regions (2016-2021)
    Table 8. Global Fabry Disease Therapeutic Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 9. Global Fabry Disease Therapeutic Market Share by Regions (2022-2027)
    Table 10. Fabry Disease Therapeutic Market Trends
    Table 11. Fabry Disease Therapeutic Market Drivers
    Table 12. Fabry Disease Therapeutic Market Challenges
    Table 13. Fabry Disease Therapeutic Market Restraints
    Table 14. Global Fabry Disease Therapeutic Revenue by Players (2016-2021) & (US$ Million)
    Table 15. Global Fabry Disease Therapeutic Market Share by Players (2016-2021)
    Table 16. Global Top Fabry Disease Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Fabry Disease Therapeutic as of 2020)
    Table 17. Ranking of Global Top Fabry Disease Therapeutic Companies by Revenue (US$ Million) in 2020
    Table 18. Global 5 Largest Players Market Share by Fabry Disease Therapeutic Revenue (CR5 and HHI) & (2016-2021)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Fabry Disease Therapeutic Product Solution and Service
    Table 21. Date of Enter into Fabry Disease Therapeutic Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Fabry Disease Therapeutic Market Size by Type (2016-2021) (US$ Million)
    Table 24. Global Fabry Disease Therapeutic Revenue Market Share by Type (2016-2021)
    Table 25. Global Fabry Disease Therapeutic Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 26. Global Fabry Disease Therapeutic Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 27. Global Fabry Disease Therapeutic Market Size Share by Application (2016-2021) & (US$ Million)
    Table 28. Global Fabry Disease Therapeutic Revenue Market Share by Application (2016-2021)
    Table 29. Global Fabry Disease Therapeutic Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 30. Global Fabry Disease Therapeutic Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 31. North America Fabry Disease Therapeutic Market Size by Type (2016-2021) (US$ Million)
    Table 32. North America Fabry Disease Therapeutic Market Size by Type (2022-2027) & (US$ Million)
    Table 33. North America Fabry Disease Therapeutic Market Size by Application (2016-2021) (US$ Million)
    Table 34. North America Fabry Disease Therapeutic Market Size by Application (2022-2027) & (US$ Million)
    Table 35. North America Fabry Disease Therapeutic Market Size by Country (2016-2021) & (US$ Million) 
    Table 36. North America Fabry Disease Therapeutic Market Size by Country (2022-2027) & (US$ Million) 
    Table 37. Europe Fabry Disease Therapeutic Market Size by Type (2016-2021) (US$ Million)
    Table 38. Europe Fabry Disease Therapeutic Market Size by Type (2022-2027) & (US$ Million)
    Table 39. Europe Fabry Disease Therapeutic Market Size by Application (2016-2021) (US$ Million)
    Table 40. Europe Fabry Disease Therapeutic Market Size by Application (2022-2027) & (US$ Million)
    Table 41. Europe Fabry Disease Therapeutic Market Size by Country (2016-2021) & (US$ Million) 
    Table 42. Europe Fabry Disease Therapeutic Market Size by Country (2022-2027) & (US$ Million) 
    Table 43. Asia-Pacific Fabry Disease Therapeutic Market Size by Type (2016-2021) (US$ Million)
    Table 44. Asia-Pacific Fabry Disease Therapeutic Market Size by Type (2022-2027) & (US$ Million)
    Table 45. Asia-Pacific Fabry Disease Therapeutic Market Size by Application (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Fabry Disease Therapeutic Market Size by Application (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Fabry Disease Therapeutic Market Size by Region (2016-2021) & (US$ Million) 
    Table 48. Asia-Pacific Fabry Disease Therapeutic Market Size by Region (2022-2027) & (US$ Million) 
    Table 49. Latin America Fabry Disease Therapeutic Market Size by Type (2016-2021) (US$ Million)
    Table 50. Latin America Fabry Disease Therapeutic Market Size by Type (2022-2027) & (US$ Million)
    Table 51. Latin America Fabry Disease Therapeutic Market Size by Application (2016-2021) (US$ Million)
    Table 52. Latin America Fabry Disease Therapeutic Market Size by Application (2022-2027) & (US$ Million)
    Table 53. Latin America Fabry Disease Therapeutic Market Size by Country (2016-2021) & (US$ Million) 
    Table 54. Latin America Fabry Disease Therapeutic Market Size by Country (2022-2027) & (US$ Million) 
    Table 55. Middle East & Africa Fabry Disease Therapeutic Market Size by Type (2016-2021) (US$ Million)
    Table 56. Middle East & Africa Fabry Disease Therapeutic Market Size by Type (2022-2027) & (US$ Million)
    Table 57. Middle East & Africa Fabry Disease Therapeutic Market Size by Application (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Fabry Disease Therapeutic Market Size by Application (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Fabry Disease Therapeutic Market Size by Country (2016-2021) & (US$ Million) 
    Table 60. Middle East & Africa Fabry Disease Therapeutic Market Size by Country (2022-2027) & (US$ Million) 
    Table 61. Amicus therapeutics Company Details
    Table 62. Amicus therapeutics Business Overview
    Table 63. Amicus therapeutics Fabry Disease Therapeutic Product
    Table 64. Amicus therapeutics Revenue in Fabry Disease Therapeutic Business (2016-2021) & (US$ Million)
    Table 65. Amicus therapeutics Recent Development
    Table 66. Takeda Company Details
    Table 67. Takeda Business Overview
    Table 68. Takeda Fabry Disease Therapeutic Product
    Table 69. Takeda Revenue in Fabry Disease Therapeutic Business (2016-2021) & (US$ Million)
    Table 70. Takeda Recent Development
    Table 71. Genzyme-Sanofi Company Details
    Table 72. Genzyme-Sanofi Business Overview
    Table 73. Genzyme-Sanofi Fabry Disease Therapeutic Product
    Table 74. Genzyme-Sanofi Revenue in Fabry Disease Therapeutic Business (2016-2021) & (US$ Million)
    Table 75. Genzyme-Sanofi Recent Development
    Table 76. Protalix Company Details
    Table 77. Protalix Business Overview
    Table 78. Protalix Fabry Disease Therapeutic Product
    Table 79. Protalix Revenue in Fabry Disease Therapeutic Business (2016-2021) & (US$ Million)
    Table 80. Protalix Recent Development
    Table 81. Sanofi-Aventis LLC Company Details
    Table 82. Sanofi-Aventis LLC Business Overview
    Table 83. Sanofi-Aventis LLC Fabry Disease Therapeutic Product
    Table 84. Sanofi-Aventis LLC Revenue in Fabry Disease Therapeutic Business (2016-2021) & (US$ Million)
    Table 85. Sanofi-Aventis LLC Recent Development
    Table 86. Novartis Pharmaceuticals Company Details
    Table 87. Novartis Pharmaceuticals Business Overview
    Table 88. Novartis Pharmaceuticals Fabry Disease Therapeutic Product
    Table 89. Novartis Pharmaceuticals Revenue in Fabry Disease Therapeutic Business (2016-2021) & (US$ Million)
    Table 90. Novartis Pharmaceuticals Recent Development
    Table 91. Pfizer Company Details
    Table 92. Pfizer Business Overview
    Table 93. Pfizer Fabry Disease Therapeutic Product
    Table 94. Pfizer Revenue in Fabry Disease Therapeutic Business (2016-2021) & (US$ Million)
    Table 95. Pfizer Recent Development
    Table 96. Bristol-Myers Squibb Company Company Details
    Table 97. Bristol-Myers Squibb Company Business Overview
    Table 98. Bristol-Myers Squibb Company Revenue in Fabry Disease Therapeutic Business (2016-2021) & (US$ Million)
    Table 99. Bristol-Myers Squibb Company Recent Development
    Table 100. GlaxoSmithKline plc Company Details
    Table 101. GlaxoSmithKline plc Business Overview
    Table 102. GlaxoSmithKline plc Fabry Disease Therapeutic Product
    Table 103. GlaxoSmithKline plc Revenue in Fabry Disease Therapeutic Business (2016-2021) & (US$ Million)
    Table 104. GlaxoSmithKline plc Recent Development
    Table 105. Amgen Inc. Company Details
    Table 106. Amgen Inc. Business Overview
    Table 107. Amgen Inc. Fabry Disease Therapeutic Product
    Table 108. Amgen Inc. Revenue in Fabry Disease Therapeutic Business (2016-2021) & (US$ Million)
    Table 109. Amgen Inc. Recent Development
    Table 110. Teva pharmaceutical Industries Ltd. Company Details
    Table 111. Teva pharmaceutical Industries Ltd. Business Overview
    Table 112. Teva pharmaceutical Industries Ltd. Fabry Disease Therapeutic Product
    Table 113. Teva pharmaceutical Industries Ltd. Revenue in Fabry Disease Therapeutic Business (2016-2021) & (US$ Million)
    Table 114. Teva pharmaceutical Industries Ltd. Recent Development
    Table 115. Merc & Co. Company Details
    Table 116. Merc & Co. Business Overview
    Table 117. Merc & Co. Fabry Disease Therapeutic Product
    Table 118. Merc & Co. Revenue in Fabry Disease Therapeutic Business (2016-2021) & (US$ Million)
    Table 119. Merc & Co. Recent Development
    Table 120. AbbVie Inc. Company Details
    Table 121. AbbVie Inc. Business Overview
    Table 122. AbbVie Inc. Fabry Disease Therapeutic Product
    Table 123. AbbVie Inc. Revenue in Fabry Disease Therapeutic Business (2016-2021) & (US$ Million)
    Table 124. AbbVie Inc. Recent Development
    Table 125. Takeda Pharmaceutical Co. Ltd. Company Details
    Table 126. Takeda Pharmaceutical Co. Ltd. Business Overview
    Table 127. Takeda Pharmaceutical Co. Ltd. Fabry Disease Therapeutic Product
    Table 128. Takeda Pharmaceutical Co. Ltd. Revenue in Fabry Disease Therapeutic Business (2016-2021) & (US$ Million)
    Table 129. Takeda Pharmaceutical Co. Ltd. Recent Development
    Table 130. Green Cross Corp. Company Details
    Table 131. Green Cross Corp. Business Overview
    Table 132. Green Cross Corp. Fabry Disease Therapeutic Product
    Table 133. Green Cross Corp. Revenue in Fabry Disease Therapeutic Business (2016-2021) & (US$ Million)
    Table 134. Green Cross Corp. Recent Development
    Table 135. Research Programs/Design for This Report
    Table 136. Key Data Information from Secondary Sources
    Table 137. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Fabry Disease Therapeutic Market Share by Type: 2020 VS 2027
    Figure 2. Enzyme Replacement Therapy Features
    Figure 3. Alternative therapies Features
    Figure 4. Global Fabry Disease Therapeutic Market Share by Application: 2020 VS 2027
    Figure 5. Hospitals Case Studies
    Figure 6. Clinics Case Studies
    Figure 7. Other Case Studies
    Figure 8. Fabry Disease Therapeutic Report Years Considered
    Figure 9. Global Fabry Disease Therapeutic Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 10. Global Fabry Disease Therapeutic Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 11. Global Fabry Disease Therapeutic Market Share by Regions: 2020 VS 2027
    Figure 12. Global Fabry Disease Therapeutic Market Share by Regions (2022-2027)
    Figure 13. Global Fabry Disease Therapeutic Market Share by Players in 2020
    Figure 14. Global Top Fabry Disease Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Fabry Disease Therapeutic as of 2020
    Figure 15. The Top 10 and 5 Players Market Share by Fabry Disease Therapeutic Revenue in 2020
    Figure 16. Global Fabry Disease Therapeutic Revenue Market Share by Type (2016-2021)
    Figure 17. Global Fabry Disease Therapeutic Revenue Market Share by Type (2022-2027)
    Figure 18. North America Fabry Disease Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 19. North America Fabry Disease Therapeutic Market Share by Type (2016-2027)
    Figure 20. North America Fabry Disease Therapeutic Market Share by Application (2016-2027)
    Figure 21. North America Fabry Disease Therapeutic Market Share by Country (2016-2027)
    Figure 22. United States Fabry Disease Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 23. Canada Fabry Disease Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Europe Fabry Disease Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe Fabry Disease Therapeutic Market Share by Type (2016-2027)
    Figure 26. Europe Fabry Disease Therapeutic Market Share by Application (2016-2027)
    Figure 27. Europe Fabry Disease Therapeutic Market Share by Country (2016-2027)
    Figure 28. Germany Fabry Disease Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. France Fabry Disease Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. U.K. Fabry Disease Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. Italy Fabry Disease Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Russia Fabry Disease Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Nordic Fabry Disease Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Asia-Pacific Fabry Disease Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific Fabry Disease Therapeutic Market Share by Type (2016-2027)
    Figure 36. Asia-Pacific Fabry Disease Therapeutic Market Share by Application (2016-2027)
    Figure 37. Asia-Pacific Fabry Disease Therapeutic Market Share by Region (2016-2027)
    Figure 38. China Fabry Disease Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Japan Fabry Disease Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. South Korea Fabry Disease Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Southeast Asia Fabry Disease Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. India Fabry Disease Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Australia Fabry Disease Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Latin America Fabry Disease Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America Fabry Disease Therapeutic Market Share by Type (2016-2027)
    Figure 46. Latin America Fabry Disease Therapeutic Market Share by Application (2016-2027)
    Figure 47. Latin America Fabry Disease Therapeutic Market Share by Country (2016-2027)
    Figure 48. Mexico Fabry Disease Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Brazil Fabry Disease Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Middle East & Africa Fabry Disease Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa Fabry Disease Therapeutic Market Share by Type (2016-2027)
    Figure 52. Middle East & Africa Fabry Disease Therapeutic Market Share by Application (2016-2027)
    Figure 53. Middle East & Africa Fabry Disease Therapeutic Market Share by Country (2016-2027)
    Figure 54. Turkey Fabry Disease Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Saudi Arabia Fabry Disease Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. UAE Fabry Disease Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Amicus therapeutics Revenue Growth Rate in Fabry Disease Therapeutic Business (2016-2021)
    Figure 58. Takeda Revenue Growth Rate in Fabry Disease Therapeutic Business (2016-2021)
    Figure 59. Genzyme-Sanofi Revenue Growth Rate in Fabry Disease Therapeutic Business (2016-2021)
    Figure 60. Protalix Revenue Growth Rate in Fabry Disease Therapeutic Business (2016-2021)
    Figure 61. Sanofi-Aventis LLC Revenue Growth Rate in Fabry Disease Therapeutic Business (2016-2021)
    Figure 62. Novartis Pharmaceuticals Revenue Growth Rate in Fabry Disease Therapeutic Business (2016-2021)
    Figure 63. Pfizer Revenue Growth Rate in Fabry Disease Therapeutic Business (2016-2021)
    Figure 64. Bristol-Myers Squibb Company Revenue Growth Rate in Fabry Disease Therapeutic Business (2016-2021)
    Figure 65. GlaxoSmithKline plc Revenue Growth Rate in Fabry Disease Therapeutic Business (2016-2021)
    Figure 66. Amgen Inc. Revenue Growth Rate in Fabry Disease Therapeutic Business (2016-2021)
    Figure 67. Teva pharmaceutical Industries Ltd. Revenue Growth Rate in Fabry Disease Therapeutic Business (2016-2021)
    Figure 68. Merc & Co. Revenue Growth Rate in Fabry Disease Therapeutic Business (2016-2021)
    Figure 69. AbbVie Inc. Revenue Growth Rate in Fabry Disease Therapeutic Business (2016-2021)
    Figure 70. Takeda Pharmaceutical Co. Ltd. Revenue Growth Rate in Fabry Disease Therapeutic Business (2016-2021)
    Figure 71. Green Cross Corp. Revenue Growth Rate in Fabry Disease Therapeutic Business (2016-2021)
    Figure 72. Bottom-up and Top-down Approaches for This Report
    Figure 73. Data Triangulation
    Figure 74. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Amicus therapeutics
Takeda
Genzyme-Sanofi
Protalix
Sanofi-Aventis LLC
Novartis Pharmaceuticals
Pfizer
Bristol-Myers Squibb Company
GlaxoSmithKline plc
Amgen Inc.
Teva pharmaceutical Industries Ltd.
Merc & Co.
AbbVie Inc.
Takeda Pharmaceutical Co. Ltd.
Green Cross Corp.
Frequently Asked Questions
Fabry Disease Therapeutic report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Fabry Disease Therapeutic report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Fabry Disease Therapeutic report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports